Anebulo Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANEB and other ETFs, options, and stocks.

About ANEB

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. 

CEO
Richard Anthony Cunningham
CEORichard Anthony Cunningham
Employees
3
Employees3
Headquarters
Lakeway, Texas
HeadquartersLakeway, Texas
Founded
2020
Founded2020
Employees
3
Employees3

ANEB Key Statistics

Market cap
116.68M
Market cap116.68M
Price-Earnings ratio
-10.65
Price-Earnings ratio-10.65
Dividend yield
Dividend yield
Average volume
2.25M
Average volume2.25M
High today
$2.90
High today$2.90
Low today
$2.67
Low today$2.67
Open price
$2.72
Open price$2.72
Volume
142.85K
Volume142.85K
52 Week high
$3.42
52 Week high$3.42
52 Week low
$0.8001
52 Week low$0.8001

People also own

Based on the portfolios of people who own ANEB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.